In case 3 and 6 in Tables 4 and 5 without pre-existing IP, KL-6 levels were elevated before anti-IL-17/23 biologics treatment, which might be associated with prior use of anti-TNF-alpha biologic. This evidence concerns the gene MUC1 and incontinentia pigmenti.